MAKO Mako Surgical Corp. (MM)

MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release second quarter 2011 financial results after market close on Monday, August 8, 2011. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the second quarter 2011 results starting at 4:30 pm ET on the same day. The call will be concurrently webcast. 

To listen to the conference call please dial 877-843-0414 for domestic callers or 914-495-8580 for international callers and enter the passcode 84118019, approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the Investor Relations section of MAKO's website at www.makosurgical.com. Following the call, a webcast replay will be available on MAKO's website, and an audio replay will also be available by calling 844-859-2056 (404-537-3406 for international callers) and entering the passcode 84118019. Both the audio and webcast replays will be available through August 15, 2011.

About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets both its RIO® Robotic-Arm Interactive Orthopedic system and its proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the insertion and alignment of MAKO's resurfacing RESTORIS implants through a minimal incision. The FDA-cleared and CE Marked RIO system allows surgeons to provide a precise, consistently reproducible tissue-sparing, bone resurfacing procedure called MAKOplasty® to a large, yet underserved patient population suffering from early to mid-stage osteoarthritic knee disease. The MAKOplasty solution is comprised of imaging, navigation, surgical procedures, haptics, robotics, software, instrument and implant technologies and is enabled by an intellectual property portfolio of more than 300 U.S. and foreign, owned and licensed, patents and patent applications, as well as copyrights, trademarks, trade secrets and employee know-how. Additional information can be found at www.makosurgical.com.

CONTACT: Investors:
         MAKO Surgical Corp.
         954-628-0753
         investorrelations@makosurgical.com
         
         or
         
         Westwicke Partners
         Mark Klausner
         443-213-0500
         makosurgical@westwicke.com